Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Nanomedicine. 2014 Sep 18;11(1):195–206. doi: 10.1016/j.nano.2014.09.004

Figure 2. Curc-np inhibit planktonic growth of Gram-positive and -negative organisms.

Figure 2

Representative 24-hour growth curves demonstrate susceptibility of (A) MRSA isolates (n=8) and (B) P. aeruginosa isolates (n=4) to control np 5 mg/ml (np), 4% DMSO control, curcumin 50 μg/ml in 4% DMSO (curc), and curc-np 5 mg/ml. Colony forming unit (CFU) quantification was performed on (C) MRSA and (D) P. aeruginosa isolates to determine antimicrobial activity of these treatment groups. All treatments were performed in triplicate. Statistical analysis conducted using 1-way and 2-way ANOVA. Error bars denote SEM. *** p≤0.0001, ** p≤0.01, * p≤0.05, ns p>0.05.